Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 20, 2025 | (Q2)Sep 20, 2024 | (Q1)Jun 20, 2024 | (FY)Mar 20, 2024 | (Q4)Mar 20, 2024 | (Q3)Dec 20, 2023 | (Q2)Sep 20, 2023 | (Q1)Jun 20, 2023 | (FY)Mar 20, 2023 | (Q4)Mar 20, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -13.07%6.31B | -8.28%1.61B | -13.19%1.52B | 12.37%7.25B | 19.42%1.77B | 20.68%1.97B | 6.45%1.76B | 3.93%1.75B | 5.52%6.46B | -0.55%1.49B |
| Cost of revenue | -13.48%5.39B | -8.94%1.37B | -14.36%1.3B | 12.38%6.24B | 19.30%1.52B | 20.40%1.69B | 6.40%1.51B | 4.45%1.52B | 5.43%5.55B | -0.95%1.27B |
| Gross profit | -10.58%911.35M | -4.31%240.21M | -5.50%218.18M | 12.30%1.02B | 20.16%257.25M | 22.38%280M | 6.74%251.02M | 0.60%230.89M | 6.08%907.56M | 1.86%214.08M |
| Operating expense | -6.42%867.14M | -3.10%208.82M | 0.92%225.91M | 6.25%926.62M | 11.46%249.15M | 8.29%238.1M | 0.29%215.51M | 4.70%223.86M | 4.04%872.1M | 5.29%223.54M |
| Operating profit | -52.22%44.21M | -11.63%31.38M | -209.91%-7.73M | 161.01%92.54M | 185.58%8.1M | 370.34%41.9M | 74.90%35.51M | -55.21%7.03M | 104.21%35.46M | -342.84%-9.46M |
| Net non-operating interest income (expenses) | -137.84%-1.14M | -655.38%-491K | -680.00%-546K | -55.81%3M | -54.03%3.48M | -37.60%-344K | -124.14%-65K | 85.97%-70K | -1.09%6.79M | 4.57%7.57M |
| Non-operating interest income | -80.10%801K | ---- | ---- | -47.36%4.03M | ---- | ---- | ---- | ---- | 4.62%7.65M | ---- |
| Non-operating interest expense | 89.16%1.94M | 655.38%491K | 680.00%546K | 19.91%1.02M | 617.11%545K | 37.60%344K | 124.14%65K | -85.97%70K | 93.65%854K | 10.14%76K |
| Net investment income | 77.80%49.85M | 139.60%22.59M | -18.76%2.9M | 36.00%28.04M | 138.42%7.65M | 5.34%7.38M | 1.79%9.43M | 215.27%3.57M | 55.30%20.61M | 117.41%3.21M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -92.49%1.35M | 201.53%18.02M | 708.90%1.99M | 102.23%200K | -310.66%-17.75M | -326K | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 0 | 0 | -103K | 0 | 0 | 0 | -103K | 0 | 0 |
| Less:Other special charges | ---- | ---- | ---- | --103K | --0 | --0 | --0 | --103K | ---- | ---- |
| Other non-operating income (expenses) | 10.10%48.78M | -13.07%11.38M | -9.03%11.77M | 5.18%44.3M | 68.86%6.79M | -6.21%11.48M | 4.23%13.09M | -2.69%12.94M | -16.35%42.12M | -1.37%4.02M |
| Income before tax | -23.01%143.05M | -12.11%64.87M | -72.64%6.4M | 112.97%185.79M | 458.08%28M | 220.31%60.62M | 119.22%73.8M | -21.13%23.37M | -9.39%87.24M | -52.92%5.02M |
| Income tax | -22.95%56.85M | -60.73%10.64M | -0.18%10.81M | 55.76%73.78M | 46.84%12.05M | 154.66%23.8M | 69.85%27.11M | -21.88%10.83M | 9.25%47.37M | 50.09%8.21M |
| Net income | -23.05%86.2M | 16.11%54.22M | -135.19%-4.41M | 180.95%112.01M | 599.97%15.95M | 284.37%36.82M | 163.72%46.7M | -20.47%12.54M | -24.66%39.87M | -161.46%-3.19M |
| Net income continuous operations | -23.05%86.2M | 16.11%54.22M | -135.18%-4.41M | 180.95%112.01M | 599.94%15.95M | 284.33%36.82M | 163.72%46.7M | -20.47%12.54M | -24.66%39.87M | -161.48%-3.19M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -23.05%86.2M | 16.11%54.22M | -135.19%-4.41M | 180.95%112.01M | 599.97%15.95M | 284.37%36.82M | 163.72%46.7M | -20.47%12.54M | -24.66%39.87M | -161.46%-3.19M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -23.05%86.2M | 16.11%54.22M | -135.19%-4.41M | 180.95%112.01M | 599.97%15.95M | 284.37%36.82M | 163.72%46.7M | -20.47%12.54M | -24.66%39.87M | -161.46%-3.19M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -22.00%38.44 | 18.69%24.19 | -136.01%-1.97 | 183.22%49.28 | 617.99%7.2 | 288.28%16.23 | 163.65%20.38 | -20.49%5.47 | -24.71%17.4 | -161.23%-1.39 |
| Diluted earnings per share | -22.00%38.44 | 18.66%24.1831 | -136.01%-1.97 | 183.22%49.28 | 611.01%7.1133 | 288.28%16.23 | 163.77%20.38 | -20.49%5.47 | -24.71%17.4 | -161.47%-1.392 |
| Dividend per share | 0.00%30 | 0 | 0 | 20.00%30 | 20.00%30 | 0 | 0 | 0 | 25.00%25 | 25.00%25 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |